83 related articles for article (PubMed ID: 1726567)
1. Effect of human alpha-fetoprotein on native and in vitro-stimulated NK activity.
Cardoso E; Valdez G; Comini E; Matera L
J Clin Lab Immunol; 1991 Apr; 34(4):183-8. PubMed ID: 1726567
[TBL] [Abstract][Full Text] [Related]
2. Effect of cortisol on the native and in vitro induced non-MHC restricted cytotoxicity of large granular lymphocytes.
Matera L; Cardoso E; Veglia F; Cesano A; Bellone G; Vuolo A; Molinatti GM
J Clin Lab Immunol; 1988 Oct; 27(2):77-81. PubMed ID: 3266762
[TBL] [Abstract][Full Text] [Related]
3. Interleukin 2 enhances the natural killer cell activity of acquired immunodeficiency syndrome patients through a gamma-interferon-independent mechanism.
Rook AH; Hooks JJ; Quinnan GV; Lane HC; Manischewitz JF; Macher AM; Masur H; Fauci AS; Djeu JY
J Immunol; 1985 Mar; 134(3):1503-7. PubMed ID: 3918102
[TBL] [Abstract][Full Text] [Related]
4. Pretreatment of human peripheral blood lymphocytes with interleukin-2 or dexamethasone does not alter their response to Met-Enkephalin in a NK-cytotoxic assay.
Martin-Kleiner I; Gabrilovac J
Immunopharmacol Immunotoxicol; 1996 Feb; 18(1):37-57. PubMed ID: 8683038
[TBL] [Abstract][Full Text] [Related]
5. Regulation of natural killer cytotoxicity by recombinant alpha interferons. Augmentation by IFN-alpha 7, an interferon similar to IFN-alpha J.
Platsoucas CD; Fox FE; Oleszak E; Fong K; Nanno M; Ioannides CG; Trotta PP
Anticancer Res; 1989; 9(4):849-58. PubMed ID: 2817813
[TBL] [Abstract][Full Text] [Related]
6. Immunomodulation of early engrafted natural killer cells with interleukin-2 and interferon-alpha in autologous stem cell transplantation.
Porrata LF; Inwards DJ; Lacy MQ; Markovic SN
Bone Marrow Transplant; 2001 Oct; 28(7):673-80. PubMed ID: 11704790
[TBL] [Abstract][Full Text] [Related]
7. 2',5'-Oligoadenylate trimer core and the cordycepin analog augment the tumoricidal activity of human natural killer cells.
Black PL; Henderson EE; Pfleiderer W; Charubala R; Suhadolnik RJ
J Immunol; 1984 Nov; 133(5):2773-7. PubMed ID: 6332860
[TBL] [Abstract][Full Text] [Related]
8. Effects of aging on natural killer cell activity and activation by interleukin-2 and IFN-alpha.
Kutza J; Murasko DM
Cell Immunol; 1994 Apr; 155(1):195-204. PubMed ID: 7513259
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of tyrosine kinase inhibition in CD69 antigen expression and lytic activity induced by rIL-2, rIL-12, and rIFN-alpha in human NK cells.
Gerosa F; Tommasi M; Benati C; Gandini G; Libonati M; Tridente G; Carra G; Trinchieri G
Cell Immunol; 1993 Sep; 150(2):382-90. PubMed ID: 8103709
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of human natural killer cell activity by the protein kinase C inhibitor 1-(5-isoquinolinesulfonyl)-2-methylpiperazine is an early but post-binding event.
Steele TA; Brahmi Z
J Immunol; 1988 Nov; 141(9):3164-9. PubMed ID: 3262683
[TBL] [Abstract][Full Text] [Related]
11. Interferon effect on cytotoxicity of peripheral blood and tumor-associated lymphocytes against human ovarian carcinoma cells.
Allavena P; Introna M; Sessa C; Mangioni C; Mantovani A
J Natl Cancer Inst; 1982 Apr; 68(4):555-62. PubMed ID: 6175786
[TBL] [Abstract][Full Text] [Related]
12. [Effect of interferon-alpha (MOR-22) on human NK cell activity].
Yanagihara Y; Tochizawa S; Ishii K; Hirai Y
Gan To Kagaku Ryoho; 1986 Feb; 13(2):342-8. PubMed ID: 3947110
[TBL] [Abstract][Full Text] [Related]
13. Immunomodulatory effects of corticosteroids on natural killer and antibody-dependent cellular cytotoxic activities of human lymphocytes.
Nair MP; Schwartz SA
J Immunol; 1984 Jun; 132(6):2876-82. PubMed ID: 6202765
[TBL] [Abstract][Full Text] [Related]
14. Recombinant interferons or interleukin-2 increase cytotoxicity by human monocytes and NK cells.
Frey JR; Kamber M; Peck R
Lymphokine Res; 1987; 6(3):215-27. PubMed ID: 3114569
[TBL] [Abstract][Full Text] [Related]
15. Comparative analysis of natural killer function in lung, spleen, and peripheral blood lymphocytes: evidence of differential characteristics.
Lauzon W; Yang H; Lemaire I
Reg Immunol; 1990-1991; 3(3):145-50. PubMed ID: 2129104
[TBL] [Abstract][Full Text] [Related]
16. Production of tumor necrosis factor-alpha and interferon-gamma from human peripheral blood lymphocytes by MGN-3, a modified arabinoxylan from rice bran, and its synergy with interleukin-2 in vitro.
Ghoneum M; Jewett A
Cancer Detect Prev; 2000; 24(4):314-24. PubMed ID: 11059563
[TBL] [Abstract][Full Text] [Related]
17. Recombinant interleukin 2 enhanced natural killer cell-mediated cytotoxicity in human lymphocyte subpopulations expressing the Leu 7 and Leu 11 antigens.
Lanier LL; Benike CJ; Phillips JH; Engleman EG
J Immunol; 1985 Feb; 134(2):794-801. PubMed ID: 3871216
[TBL] [Abstract][Full Text] [Related]
18. Cytokines alter target cell susceptibility to lysis: I. Evaluation of non-major histocompatibility complex-restricted effectors reveals differential effects on natural and lymphokine-activated killing.
Wiebke EA; Custer MC; Rosenberg SA; Lotze MT
J Biol Response Mod; 1990 Apr; 9(2):113-26. PubMed ID: 2111373
[TBL] [Abstract][Full Text] [Related]
19. Modulation of murine natural killer cell activity in vitro and in vivo by recombinant human interferons.
Brunda MJ; Rosenbaum D
Cancer Res; 1984 Feb; 44(2):597-601. PubMed ID: 6692364
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of human natural killer cell activity by a synthetic peptide homologous to a conserved region in the retroviral protein, p15E.
Harris DT; Cianciolo GJ; Snyderman R; Argov S; Koren HS
J Immunol; 1987 Feb; 138(3):889-94. PubMed ID: 2433333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
